Next generation sequencing for DLBCL classification
Topic Status Complete
Next generation sequencing for DLBCL classification (HTG EdgeSeq DLBCL Cell of Origin Assay).
HTW researchers searched for evidence on the effectiveness of the HTG EdgeSeq DLBCL Cell of Origin Assay, an in vitro diagnostic assay which is used to determine cell of origin in people with diffuse large B-cell lymphoma.
HTW’s Assessment Group concluded not to progress this topic further at the present time, although this topic may be revisited in future and its suitability for fuller assessment reconsidered.
Access our guidance
Our advice documents are free to download, but we would be grateful if you could help us improve our services by telling us why you are looking at our advice and how you intend to use it.